Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.33 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.33 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.33 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.32 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.32 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.32 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11246030 | 0.78 | TSHR (0.39) | TSHRALDH1A1MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL474670 | 0.78 | — | — | |
| SCHEMBL11671624 | 0.77 | TSHR (0.37) | TSHRALDH1A1OPRM1DPP8DPP7 | |
| SCHEMBL2794842 | 0.75 | TSHR (0.39) | TSHRALDH1A1MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL27657804 | 0.75 | TSHR (0.36) | TSHRALDH1A1TDP1MEN1KMT2A | |
| SCHEMBL11196311 | 0.75 | TSHR (0.36) | TSHRALDH1A1MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL28634941 | 0.75 | TSHR (0.39) | TSHRALDH1A1OPRM1MEN1KMT2A | |
| SCHEMBL3875953 | 0.75 | — | — | |
| SCHEMBL5671681 | 0.75 | OPRM1 (0.40) | ALDH1A1OPRM1DPP7SLC1A3SLC1A2 | |
| SCHEMBL31124930 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7872155-B2 | Method of deprotection of alkyl arylamine ethers | XEROX CORPORATION (US) | 2011-01-18 | — | — | US | claimed |
| US-20090131721-A1 | METHOD OF DEPROTECTION OF ALKYL ARYLAMINE ETHERS | XEROX CORPORATION (US) | 2009-05-21 | — | — | US | claimed |
| US-7872155-B2 | Method of deprotection of alkyl arylamine ethers | XEROX CORPORATION (US) | 2011-01-18 | — | — | US | disclosed |
| US-7872155-B2 | Method of deprotection of alkyl arylamine ethers | XEROX CORPORATION (US) | 2011-01-18 | — | — | US | disclosed |
| US-7872155-B2 | Method of deprotection of alkyl arylamine ethers | XEROX CORPORATION (US) | 2011-01-18 | — | — | US | disclosed |
| US-20090131721-A1 | METHOD OF DEPROTECTION OF ALKYL ARYLAMINE ETHERS | XEROX CORPORATION (US) | 2009-05-21 | — | — | US | disclosed |
| US-20090131721-A1 | METHOD OF DEPROTECTION OF ALKYL ARYLAMINE ETHERS | XEROX CORPORATION (US) | 2009-05-21 | — | — | US | disclosed |
| US-20090131721-A1 | METHOD OF DEPROTECTION OF ALKYL ARYLAMINE ETHERS | XEROX CORPORATION (US) | 2009-05-21 | — | — | US | disclosed |
| US-6331648-B1 | Ether amines and derivatives | NOVA MOLECULAR TECHNOLOGIES INC | 2001-12-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090131721-A1 | METHOD OF DEPROTECTION OF ALKYL ARYLAMINE ETHERS | NAT1, PNMT, AADAC | TSHR 226/4885ALDH1A1 468/4885OPRM1 999/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.